🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to evaluate the safety, toxicities, an...
Status
Completed
Location
University of Rochester Cancer Center
Start Date
TBD
Trial ID
NCT00080041
Treatments Being Tested
Monoclonal antibodies such as rituximab and yttrium Y 90 ibritumomab tiuxet...
Status
Terminated
Location
Northwestern University
Start Date
2003-10-28
Trial ID
NCT00089284
Treatments Being Tested
The purpose of the study is to determine if the drug motexafin gadolinium w...
Status
Completed
Location
Robert H. Lurie Comprehensive Cancer Center
Start Date
TBD
Trial ID
NCT00096837
Treatments Being Tested
The primary purpose of the study is to determine if patients with brain met...
Status
Completed
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00054795
Treatments Being Tested
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells....
Status
Completed
Location
Marin Oncology Associates, Inc.
Start Date
1998-08
Trial ID
NCT00003563
The purpose of this study is to find out about the safety of adding the inv...
Status
Completed
Location
Barrow Neurological Institute
Start Date
TBD
Trial ID
NCT00080054
Treatments Being Tested
The purpose of the study is to determine the dose limiting toxicities and m...
Status
Completed
Location
The University of Texas MD Anderson Cancer Center
Start Date
2004-11
Trial ID
NCT00102505
Treatments Being Tested
The purpose of this study is to evaluate the safety of adding the investiga...
Status
Terminated
Location
Duke University Medical Center
Start Date
TBD
Trial ID
NCT00080028
Treatments Being Tested